首页|2020-2021年我院中药注射剂专项处方点评与分析

2020-2021年我院中药注射剂专项处方点评与分析

扫码查看
目的 分析东莞市长安医院(以下简称"我院")中药注射剂的不合理用药情况,为促进临床合理用药提供参考依据。方法 利用院内HIS系统,对我院住院病区 19 个品种 24 个品规的中药注射剂进行回顾性点评分析。随机抽查2020年1月至2021年12月我院出院病历,每月随机抽取出院归档病历80份,共抽取病历1920份。结果 抽查病历中,2020 年医嘱不合理率为 32。08%(308/960),2021 年医嘱不合理率为 9。06%(87/960),1 920 份病历中不合理类型排名前 3 位的是适应证不适宜、溶媒选择与溶媒用量不合理、用法用量不合理。结论 通过中药注射剂专项处方点评,发挥临床药师药学干预作用,我院规范了中药注射剂的使用,后续还应继续加强处方点评与审核以及开展相关培训,降低中药注射剂不良反应率,提高我院整体合理用药水平。
Review and Analysis of Special Prescriptions for Traditional Chinese Medicine Injections in Our Hospital from 2020 to 2021
Objective To analyze the irrational use of traditional Chinese medicine(TCM)injections in Dongguan Chang'an Hospital(hereinafter referred to as"our hospital")and provide reference for promoting clinical medication.Methods Using the hospital HIS system,retrospectively reviewed and analyzed 19 varieties and 24 quality specifications of TCM injections in our hospital's inpatient areas.Randomly check the discharged medical records of our hospital from January 2020 to December 2021,and randomly select 80 discharged and archived medical records every month,with a total of 1 920 medical records selected.Results In 2020,the irrational rate of TCM orders in medical records was 32.08%(308/960),and in 2021,the irrational rate of medical orders was 9.06%(87/960).Among 1 920 medical records,the top three unreasonable types were inappropriate indications,unreasonable choice and dosage of solvents,and unreasonable usage and dosage.Conclusion Through the review of special prescriptions for TCM injections and the role of clinical pharmacists in pharmaceutical intervention,our hospital has standardized the use of TCM injections.In the future,we should continue to strengthen the review and review of prescriptions and carry out relevant training,reduce the occurrence of adverse reactions of TCM,and improve the level of rational medication in our hospital.

Traditional Chinese medicine injectionsSpecial prescription reviewAnalysis

陈丽思、陈归荣、黄晓玲

展开 >

东莞市长安医院,广东 东莞 523843

中药注射剂 专项处方点评 分析

2024

药品评价
江西省药学会

药品评价

影响因子:0.672
ISSN:1672-2809
年,卷(期):2024.21(5)